ROYAL BANK OF CANADA - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 38 filers reported holding OCUPHIRE PHARMA INC in Q2 2021. The put-call ratio across all filers is 4.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$52,000
-44.1%
15,405
-28.0%
0.00%
Q2 2023$93,00021,405
+428000.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$050.0%0.00%
Q3 2022$050.0%0.00%
Q2 2022$050.0%0.00%
Q1 2022$050.0%0.00%
Q4 2021$050.0%0.00%
Q3 2021$050.0%0.00%
Q2 2021$050.0%0.00%
Q1 2021$050.0%0.00%
Q4 2020$050.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 320,332$641,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 540,348$1,086,0000.06%
Eidelman Virant Capital 25,000$51,0000.04%
Diametric Capital, LP 24,548$49,0000.02%
MAI Capital Management 356,948$717,0000.01%
Bedel Financial Consulting, Inc. 15,000$31,0000.01%
Warberg Asset Management LLC 21,000$42,0000.01%
Cornerstone Capital, Inc. 13,857$28,0000.00%
Stokes Family Office, LLC 12,120$24,0000.00%
CarsonAllaria Wealth Management, Ltd. 1,000$2,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders